Acylcarnitinepatternserplimp
Acylcarnitine pattern testing measures specific substances in blood to help detect metabolic disorders that affect how the body processes fats for energy.
{"This blood test checks for abnormal levels of acylcarnitines, which can indicate metabolic diseases","It is commonly used to screen newborns for fatty acid oxidation disorders","The test helps doctors diagnose conditions that can cause low blood sugar, muscle weakness, or developmental delays","Abnormal results may require additional testing for confirmation","Early detection through newborn screening can prevent serious complications"}
Key facts at a glance
- LOINC
- 46252-3
- Short code
- ACYPAT
- Synonyms
- Acylcarnitine pattern SerPl-Imp
- Category
- chemistry
- Sample
- serum
- Container
- EDTA plasma (lavender top) or Serum separator tube (SST)
- Units
- N/A
- Ref low
- 0
- Ref high
- 17
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- Tandem Mass Spectrometry (MS/MS) with interpretation of acylcarnitine profile pattern
- CPT
- 82017
- SNOMED
- 314862001
- Specimen volume
- 0.5-1 mL minimum, 2-3 mL preferred
- Stability
- Room temperature: 24 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 30 days. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 50
- Lipemia max
- 100
- Icterus max
- 20
- TAT
- 72–168 hours
- Order
- routine
What is this test?
The acylcarnitine profile test is a blood test that measures the levels of different acylcarnitine compounds in your blood. Acylcarnitines are substances produced when your body breaks down fatty acids for energy. This test helps doctors detect abnormalities in how your body processes fats, which can indicate certain metabolic disorders.
Why is it done?
This test is primarily used as part of newborn screening programs to identify babies with fatty acid oxidation disorders and organic acidemias before symptoms appear. It may also be performed in older children and adults when doctors suspect a metabolic disorder causing symptoms such as low blood sugar, muscle weakness, heart problems, or developmental delays.
How is the sample collected?
A healthcare professional will draw a small blood sample from a vein in your arm or, for newborns, from a heel stick. The blood is collected on a special filter paper card and sent to a laboratory for analysis. The procedure is quick and generally causes minimal discomfort.
What do the results mean?
Results show the levels of different types of acylcarnitines. Abnormal levels of specific acylcarnitine compounds can indicate different metabolic disorders. Your doctor will interpret the pattern of results to determine if further testing is needed to confirm a diagnosis.
Reference range
NCBI: NSE 0-17 ng/mLN/A
No fasting required. Specimen should be collected prior to feeding in newborns. Inform laboratory of patient's clinical history including symptoms, family history of metabolic disorders, and current medications.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Frequently asked questions
Do I need to fast before this test?
Is this test only for newborns?
What happens if my baby's test is abnormal?
Are there risks from this test?
How long does it take to get results?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy